ArdorComm Media News Network
June 2, 2026
Bangladesh’s measles outbreak has claimed two more lives, pushing the total death toll to 585 since March 15, according to health authorities.
The latest fatalities, both involving children, were reported within a 24-hour period ending Sunday morning and have been classified as suspected measles deaths by the Directorate General of Health Services (DGHS).
With these additions, the number of suspected measles-related deaths has risen to 495, while 90 deaths have been officially confirmed. The outbreak continues to place significant pressure on the country’s healthcare system, with 1,324 new suspected cases reported over the past day. This has increased the cumulative number of suspected infections to 70,936. Meanwhile, 53 new confirmed cases were recorded, taking the total confirmed infections to 9,049.
Since mid-March, 56,886 people with suspected measles symptoms have been hospitalised across Bangladesh. Of these, 52,841 patients have recovered, according to DGHS data.
The crisis has also sparked concerns over vaccine availability. Last week, UNICEF revealed that it had repeatedly warned Bangladesh’s previous interim administration, led by Muhammad Yunus, about vaccine shortages that could lead to a widespread outbreak.
Speaking at a media briefing in Dhaka, UNICEF Bangladesh Representative Rana Flowers said the organisation had sent multiple letters and raised the issue during at least 10 meetings with health officials between 2024 and 2026. According to Flowers, UNICEF consistently cautioned authorities that delays in vaccine procurement could trigger a major public health emergency.
She further noted that UNICEF Deputy Executive Director Ted Chaiban had also highlighted the issue during discussions with Bangladesh’s Foreign Ministry during his visit to the country last year.
UNICEF has pledged to support the ongoing investigation launched by the current BNP-led government and provide relevant evidence regarding the vaccine shortage and the subsequent outbreak.
Source: IANS

